BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26658239)

  • 1. Associations between intensive diabetes therapy and NMR-determined lipoprotein subclass profiles in type 1 diabetes.
    Zhang Y; Jenkins AJ; Basu A; Stoner JA; Lopes-Virella MF; Klein RL; ; Lyons TJ
    J Lipid Res; 2016 Feb; 57(2):310-7. PubMed ID: 26658239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance.
    Garvey WT; Kwon S; Zheng D; Shaughnessy S; Wallace P; Hutto A; Pugh K; Jenkins AJ; Klein RL; Liao Y
    Diabetes; 2003 Feb; 52(2):453-62. PubMed ID: 12540621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear magnetic resonance-determined lipoprotein subclass profile in the DCCT/EDIC cohort: associations with carotid intima-media thickness.
    Lyons TJ; Jenkins AJ; Zheng D; Klein RL; Otvos JD; Yu Y; Lackland DT; McGee D; McHenry MB; Lopes-Virella M; Garvey WT;
    Diabet Med; 2006 Sep; 23(9):955-66. PubMed ID: 16922701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear magnetic resonance-determined lipoprotein subclasses and carotid intima-media thickness in type 1 diabetes.
    Basu A; Jenkins AJ; Zhang Y; Stoner JA; Klein RL; Lopes-Virella MF; Garvey WT; Lyons TJ;
    Atherosclerosis; 2016 Jan; 244():93-100. PubMed ID: 26600440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease.
    Soedamah-Muthu SS; Colhoun HM; Thomason MJ; Betteridge DJ; Durrington PN; Hitman GA; Fuller JH; Julier K; Mackness MI; Neil HA;
    Atherosclerosis; 2003 Apr; 167(2):243-55. PubMed ID: 12818407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort.
    Lyons TJ; Jenkins AJ; Zheng D; Lackland DT; McGee D; Garvey WT; Klein RL
    Invest Ophthalmol Vis Sci; 2004 Mar; 45(3):910-8. PubMed ID: 14985310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy.
    Jenkins AJ; Lyons TJ; Zheng D; Otvos JD; Lackland DT; McGee D; Garvey WT; Klein RL;
    Kidney Int; 2003 Sep; 64(3):817-28. PubMed ID: 12911531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes.
    Colhoun HM; Otvos JD; Rubens MB; Taskinen MR; Underwood SR; Fuller JH
    Diabetes; 2002 Jun; 51(6):1949-56. PubMed ID: 12031985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.
    Otvos JD; Collins D; Freedman DS; Shalaurova I; Schaefer EJ; McNamara JR; Bloomfield HE; Robins SJ
    Circulation; 2006 Mar; 113(12):1556-63. PubMed ID: 16534013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein subclass profiles of hyperlipidemic diabetic mice measured by nuclear magnetic resonance spectroscopy.
    Hammad SM; Powell-Braxton L; Otvos JD; Eldridge L; Won W; Lyons TJ
    Metabolism; 2003 Jul; 52(7):916-21. PubMed ID: 12870170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study.
    Soedamah-Muthu SS; Chang YF; Otvos J; Evans RW; Orchard TJ;
    Diabetologia; 2003 May; 46(5):674-82. PubMed ID: 12743701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia.
    Jenkins AJ; Lyons TJ; Zheng D; Otvos JD; Lackland DT; McGee D; Garvey WT; Klein RL;
    Diabetes Care; 2003 Mar; 26(3):810-8. PubMed ID: 12610042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced lipoprotein profile disturbances in type 1 diabetes mellitus: a focus on LDL particles.
    Amor AJ; Castelblanco E; Hernández M; Gimenez M; Granado-Casas M; Blanco J; Soldevila B; Esmatjes E; Conget I; Alonso N; Ortega E; Mauricio D
    Cardiovasc Diabetol; 2020 Aug; 19(1):126. PubMed ID: 32772924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of lipoprotein subclasses by proton nuclear magnetic resonance-based partial least-squares regression models.
    Petersen M; Dyrby M; Toubro S; Engelsen SB; Nørgaard L; Pedersen HT; Dyerberg J
    Clin Chem; 2005 Aug; 51(8):1457-61. PubMed ID: 15961551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus : Secondary Analysis of a Randomized Clinical Trial.
    Dugani SB; Akinkuolie AO; Paynter N; Glynn RJ; Ridker PM; Mora S
    JAMA Cardiol; 2016 May; 1(2):136-45. PubMed ID: 27347563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia.
    Cheung MC; Austin MA; Moulin P; Wolf AC; Cryer D; Knopp RH
    Atherosclerosis; 1993 Aug; 102(1):107-19. PubMed ID: 8257447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic lipase and lipoprotein lipase are not major determinants of the low density lipoprotein subclass pattern in human subjects with coronary heart disease.
    Jansen H; Hop W; van Tol A; Bruschke AV; Birkenhäger JC
    Atherosclerosis; 1994 May; 107(1):45-54. PubMed ID: 7945558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein particle size and concentration by nuclear magnetic resonance and incident type 2 diabetes in women.
    Mora S; Otvos JD; Rosenson RS; Pradhan A; Buring JE; Ridker PM
    Diabetes; 2010 May; 59(5):1153-60. PubMed ID: 20185808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein C-III protein concentrations and gene polymorphisms in type 1 diabetes: associations with lipoprotein subclasses.
    Klein RL; McHenry MB; Lok KH; Hunter SJ; Le NA; Jenkins AJ; Zheng D; Semler AJ; Brown WV; Lyons TJ; Garvey WT;
    Metabolism; 2004 Oct; 53(10):1296-304. PubMed ID: 15375785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predominance of large low density lipoprotein particles and lower fractional esterification rate of cholesterol in high density lipoprotein in children with insulin-dependent diabetes mellitus.
    Ohta T; Nishiyama S; Nakamura T; Saku K; Maung KK; Matsuda I
    Eur J Pediatr; 1998 Apr; 157(4):276-81. PubMed ID: 9578960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.